title: Genetic Predisposition to Diabetic Nephropathy: Evidence for a Role of ACE (I/D) Gene Polymorphism in Type 2 Diabetic Population from Kutch Region.
abstract: Genetic polymorphism as described with angiotensin-converting enzyme gene has been proposed as a putative mediator of diabetic nephropathy. We substantiate the hypothesis that genetic variants of the ACE have significant impacts on diabetic nephropathy. To assess the possible association between the three ACE polymorphic variants and DN in an ethnically homogeneous type 2 diabetic population from Kutch region. A 287-bp insertion/deletion polymorphism in intron 16 of the ACE gene was examined by polymerase chain reaction using a case-control approach conducted with 309 unrelated type 2 diabetic patients of Kutch origin (159 Ahir and 150 Rabari, with >10 years duration of T2DM). Of the patients, 143 had nephropathy {AER >30 mg/day (Ahir, n:73 and Rabari, n:70)} and were considered as cases; all others {n:166 (86 Ahir and 80 Rabari)} were normoalbuminuric (AER <30 mg/day) and were treated as controls. Suitable descriptive statistics was used for different variables. Genotype frequencies in all groups were all in accordance with the Hardy-Weinberg equilibrium. Genotypic distribution was significantly different between cases and controls (Ahir: x(2) :8.87, 2 d.f. p = 0.0118; Rabari: x(2) :11.01, 2 d.f. p = 0.0041). Multivariate logistic regression analysis revealed that DD genotype was a significant and strongest independent predictor of microalbuminuria (Ahir: p = 0.0362, OR = 2.65, 95 % CI 1.89-6.36; Rabari: p = 0.024, OR = 2.81, 95 % CI 1.9-6.65). However, it did not independently change the odds of having macroalbuminuria versus microalbuminuria. Analysis of the association under various genetic models revealed that ACE I/D polymorphic variant contribute to DN susceptibility under recessive mode only. Genetic variation at the ACE locus as D/D variant in intron 16, contribute to an increased risk of nephropathy in T2DM patients but not extent of DN severity, and thus this polymorphism might be considered as genetic risk factors for DN among patients with type 2 diabetes.
authors: G.K.General Hospital, Gujarat Adani Institute of Medical Sciences, H/No-B/10 New, Bhuj, Gujarat India.
authors: Deepak N
authors: DN
authors: Parchwani
authors: G.K.General Hospital, Gujarat Adani Institute of Medical Sciences, H/No-B/10 New, Bhuj, Gujarat India.
authors: Kamlesh M
authors: KM
authors: Palandurkar
authors: G.K.General Hospital, Gujarat Adani Institute of Medical Sciences, H/No-B/10 New, Bhuj, Gujarat India.
authors: D
authors: D
authors: Hema Chandan Kumar
authors: G.K.General Hospital, Gujarat Adani Institute of Medical Sciences, H/No-B/10 New, Bhuj, Gujarat India.
authors: Darshan J
authors: DJ
authors: Patel
keywords: ACE I/D; Polymerase chain reaction; Type 2 diabetes mellitus
references: Diabetes Care. 2004 Jan;27 Suppl 1:S79-83
references: 14693934
references: Am J Kidney Dis. 1999 Jun;33(6):1064-70
references: 10352194
references: BMC Med Genet. 2006 May 03;7:42
references: 16672053
references: J Clin Invest. 1990 Oct;86(4):1343-6
references: 1976655
references: J Clin Pathol. 1969 Mar;22(2):158-61
references: 5776547
references: J Biol Chem. 1991 Aug 15;266(23):15377-83
references: 1651327
references: Arch Intern Med. 2010 Jan 25;170(2):155-61
references: 20101010
references: J Diabetes Complications. 2008 May-Jun;22(3):164-70
references: 18413219
references: Clin Chem. 1974 Apr;20(4):470-5
references: 4818200
references: Diabetologia. 2005 May;48(5):1008-16
references: 15830182
references: Diabet Med. 2006 Mar;23(3):331-4
references: 16492220
references: Diabetes Metab Res Rev. 2009 Nov;25(8):717-24
references: 19787680
references: Lancet. 2004 Jan 10;363(9403):157-63
references: 14726171
references: Monogr Ser World Health Organ. 1968;56:1-188
references: 4972212
references: Diabet Med. 2003 Aug;20(8):677-82
references: 12873298
references: Tech Bull Regist Med Technol. 1960 Dec;30:207-12
references: 13692569
references: Am J Epidemiol. 2009 Feb 15;169(4):505-14
references: 19126586
references: J Renin Angiotensin Aldosterone Syst. 2012 Mar;13(1):161-74
references: 21810896
references: J Renin Angiotensin Aldosterone Syst. 2008 Mar;9(1):32-6
references: 18404607
references: Am J Med. 2010 Mar;123(3 Suppl):S3-11
references: 20206730
references: Mol Cell Biochem. 2011 Jan;346(1-2):23-30
references: 20830509
references: J Renin Angiotensin Aldosterone Syst. 2011 Dec;12(4):572-80
references: 21421655
references: J Renin Angiotensin Aldosterone Syst. 2009 Mar;10(1):1-8
references: 19286752
references: J Am Soc Nephrol. 2009 Dec;20(12):2641-50
references: 19926893
references: J Hypertens Suppl. 1994 Jul;12(4):S51-8
references: 7965275
references: Semin Dial. 2010 Mar-Apr;23(2):129-33
references: 20210917
references: Indian J Hum Genet. 2010 May;16(2):78-86
references: 21031056
references: Am J Hum Genet. 1992 Jul;51(1):197-205
references: 1319114
references: Clin Chem. 2006 Jan;52(1):5-18
references: 16332993
references: Nephrol Dial Transplant. 2006 Aug;21(8):2178-83
references: 16595584
references: Br J Clin Pharmacol. 1994 Feb;37(2):212-4
references: 8186067
references: Nucleic Acids Res. 1987 Nov 25;15(22):9611
references: 3684611
references: Nephrology (Carlton). 2005 Oct;10 Suppl:S22-5
references: 16174283
references: Nephrol Dial Transplant. 2000 Jul;15(7):1008-13
references: 10862639
references: J Mol Diagn. 2000 Aug;2(3):105-15
references: 11229513
references: Life Sci. 1969 Apr 15;8(8):345-8
references: 5797864
references: Clin Chem. 1990 Mar;36(3):446-9
references: 2311211
references: J Clin Lab Anal. 1999;13(1):5-8
references: 10025731
references: J Diabetes Complications. 2007 Jul-Aug;21(4):237-41
references: 17616353
references: N Engl J Med. 1995 Mar 16;332(11):706-11
references: 7854377
references: JAMA. 2003 May 21;289(19):2560-72
references: 12748199
references: J Diabetes Complications. 2008 May-Jun;22(3):186-90
references: 18413162
references: Am J Nephrol. 2009;29(4):299-308
references: 18849600
references: Clin Chim Acta. 1984 Jun 27;140(1):77-83
references: 6744629
references: Am J Kidney Dis. 2000 Sep;36(3):449-67
references: 10977776
references: Diabetes. 2002 Jun;51(6):1986-8
references: 12031990
references: Indian J Nephrol. 2009 Oct;19(4):145-8
references: 20535249
references: Kidney Int. 1981 Mar;19(3):410-5
references: 7241881
references: Diabetes Care. 1985 Mar-Apr;8(2):114-7
references: 3873328
references: Pharmacol Rev. 2000 Mar;52(1):11-34
references: 10699153
references: DNA Cell Biol. 2009 Mar;28(3):141-50
references: 19108684
references: J Am Soc Nephrol. 2001 Mar;12(3):541-549
references: 11181802
references: J Int Med Res. 2003 Jul-Aug;31(4):290-8
references: 12964504
references: Diabetes Res Clin Pract. 1999 Mar;43(3):167-71
references: 10369425
references: J Med Genet. 1996 Apr;33(4):336-7
references: 8730292
references: Clin Nephrol. 2012 Apr;77(4):332-44
references: 22445478
references: Nucleic Acids Res. 1992 Mar 25;20(6):1433
references: 1313972
references: J Renin Angiotensin Aldosterone Syst. 2012 Dec;13(4):472-7
references: 22554825
references: Curr Diabetes Rev. 2008 Feb;4(1):63-78
references: 18220697
references: Clin Chem. 1982 Oct;28(10):2077-80
references: 6812986
references: Diabetes Technol Ther. 2010 Feb;12(2):161-6
references: 20105047
references: Lancet. 2005 Oct 8;366(9493):1315-23
references: 16214603
references: Biophys Chem. 2008 Mar;133(1-3):66-70
references: 18201813
references: Diabetes. 2002 Jan;51(1):251-5
references: 11756350
references: Exp Mol Med. 2004 Aug 31;36(4):345-50
references: 15365253
references: J Hum Genet. 2007;52(2):143-151
references: 17143591
references: J Endocrinol Invest. 2009 Oct;32(9):746-51
references: 20009501
references: Ann Hum Biol. 2006 May-Jun;33(3):319-29
references: 17092869
references: Am J Hum Genet. 2002 Feb;70(2):461-71
references: 11791213
references: Diabetes Care. 2003 Aug;26(8):2392-9
references: 12882868
references: Med Clin (Barc). 2007 Jun 2;129(1):6-10
references: 17570179